PapersPMID:34584225
Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.
- findings
- 4
- compound
- 1
- endpoints
- 4
- no difference found
- 2
taurine- Study, every finding
- meta-analysis
- Population, every finding
- participants in controlled clinical trials of taurine supplementation
What moved
How to read these marks →“Tau supplementation can reduce the levels of malondialdehyde (MDA) (SMD = -1.17 µmol/l; 95% CI: -2.08, - 0.26; P = 0.012) and C-reactive protein (CRP) (SMD = -1.95 mg/l; 95% CI: -3.20, - 0.71; P = 0.002).”
- Decreases malondialdehyde (circulating)
very limited
- Effect
- −1.17 standardised mean difference, 95% CI −2.08 to −0.26
- Decreases C-reactive protein concentration
very limited
- Effect
- −1.95 standardised mean difference, 95% CI −3.2 to −0.71
What did not
“There have been no significant effects of Tau supplementation on the levels of tumor necrosis factors-alpha (TNF-α) (SMD = -0.18 pg/ml; 95% CI: -0.56, 0.21; P = 0.368), and interleukin-6 (IL-6) (SMD = -0.49 pg/ml; 95% CI: -1.13, 0.16; P = 0.141).”
- Effect
- −0.18 standardised mean difference, 95% CI −0.56 to 0.21
- Effect
- −0.49 standardised mean difference, 95% CI −1.13 to 0.16
Study record
- Design
- meta-analysis
- Species
- human
- Population
- participants in controlled clinical trials of taurine supplementation
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 5